Differential role of the lectin pathway


Friday - May 6, 2011

Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis.
Schlapbach, L et al. CID 2010, 51:153

Incidence of bacterial sepsis during the neonatal period:
The incidence of bacterial sepsis during the neonatal period is high. Innate immunity plays an important role in the defense of neonates against invasive infections. Mannan-binding lectin (MBL), L-ficolin, and H-ficolin recognize microorganisms and activate the complement system via MBL-associated serine proteases (MASPs). However, the entire lectin pathway has never been studied in patients with sepsis.
Cord blood concentrations of the lectin proteins:
This study investigated whether cord blood concentrations of the lectin pathway proteins are associated with neonatal sepsis. This was a case-control study including 47 infants with culture-proven sepsis during the first month of life and 94 matched controls. Lectin pathway concentrations were measured in cord blood with use of enzyme-linked immunosorbent assay (MBL, L-ficolin, MASP-2)  and time-resolved immunofluorometric assay (H-ficolin, MASP-3). Multivariate logistic regression was performed.
Different results infants with gram-positive and gram-negative sepsis:
Infants with gram-positive sepsis had significantly lower H-ficolin cord blood concentrations than controls (multivariate odds ratio [OR], 4.00; 95% confidence interval [CI], 1.51–10.56;p=.005), whereas infants with gram-negative sepsis had lower MBL cord blood concentrations (OR, 2.99; 95% CI, 0.86–10.33; p=.084).
When excluding patients with postoperative sepsis, multivariate analysis confirmed that low H-ficolin was associated with a significantly higher risk of gram-positive sepsis (OR, 3.71; 95% CI, 1.26–10.92; p=.017) and late-onset sepsis (OR, 3.14; 95% CI, 1.07–9.21; p=.037). In contrast, low MBL was associated with a significantly higher risk of gram-negative sepsis (OR, 4.39; 95% CI, 1.10–17.45; p=.036) and early-onset sepsis (OR, 3.87; 95% CI, 1.05–14.29; p=.042). The concentrations of all the lectin pathway proteins increased with gestational age (p< 0.01).
Conclusions:
These results indicate that low MBL concentrations are a susceptibility factor for gram-negative sepsis, and low H-ficolin concentrations indicate susceptibility to gram-positive sepsis. The decreased expression of lectin pathway proteins in neonates must be considered to be an additional form of neonatal immunodeficiency.

Other news
Nate: Hycult Biotech's Mascot Read this article » Immunology 2012, May 4th -8th, Boston, MA Read this article » New Antibody Sampler Packs US Read this article » New: Flow Cytometry Brochure! Read this article » NEW: Human Properdin ELISA Read this article » Low Endotoxin Antibodies for Functional Studies Read this article » BSA-free Antibodies for Immuno Assays Read this article » Now available: 1-plate assays! Read this article » Special Formulations and Service Read this article » 2012 US Hycult Biotech Catalog Read this article » Discounts for Publication References Read this article » Government Accounts Read this article » American Assoc. of Immunology Meeting Read this article » Human Properdin ELISA and mAbs Read this article » Immuno Assay mAbs Read this article » Single-Plate ELISAs Read this article » Functional Study, Low Endotoxin mAbs Read this article » PTX3, a biomarker for vascular inflammation Read this article » Upgrade I-FABP ELISA (Cat.#HK406) Read this article » Visit us at MEDICA Read this article » New R-PE monoclonals available Read this article » Hycult Biotech Inc Bronze Sponsor SLB Read this article » NEW product: Human CRP ELISA Read this article » Hycult Biotech Gold Sponsor EMCHD 2011 Read this article » Discount Human LBP ELISA and Human sCD14 ELISA Read this article » Variant-specific quantification of factor H Read this article » Increased Exposure to Bacterial Antigen RpL7/L12 Read this article » IgG glycan hydrolysis Read this article » C1q deficiency linked to autoimmune disorders Read this article » New Complement Proteins available Read this article » Formation of Hycult Biotech Inc. Read this article » New Human Complement Factor D ELISA Read this article » Unique ELISA to elucidate the role of human MASP-3 Read this article » Mast cells, basophils and eosinophils Read this article » Unique antibodies for functional studies Read this article » C1q product release Read this article » Human SAA ELISA Read this article »